Pay in 4 interest-free payments of $4.84 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Pay in 4 interest-free payments of $4.84 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Cáncer de próstata metastásico
ENSPRYNG® 120 mg/mL es un medicamento biológico de uso subcutáneo que contiene Satralizumab
Etapa G 9-13 Kg
00 MG OMEGA 9 35
Micofenolato de sodio 180 mg
AC NUVEL HUMECTANTE P/BEBE 125ML CLORFENAMINA 3.00 MG AMANTADINA 50.00 MG PARACETAMOL 300.00 MG Cáncer de próstata metastásico
US$ 77250.00
US$ 10550.00